Clinical trial
Giant Cell Arteritis - Examination of the Optimal Diagnostic Pathway
NCT05248906 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Giant Cell Arteritis - Examination of the Optimal Diagnostic Pathway
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 19, 2021
- Completion date
- January 1, 2024
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.